Every 8-K that REGIONAL HEALTH PRTYS INC (RHEP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow RHEP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RHEP filings page.
Regional Health Properties, Inc. appointed Marlie Davis, CPA, MBA, as Chief Financial Officer, effective May 1, 2026. She will serve as the company’s principal financial and principal accounting officer. Davis brings over 20 years of finance, accounting, audit and real estate investment experience at multiple firms.
Under her offer letter, Davis will receive an initial annual base salary of $265,000 and be eligible for a discretionary annual bonus with a $100,000 target. Subject to equity plan approvals, she will be granted 35,000 restricted stock units and an option to purchase 35,000 shares of common stock, plus eligibility for standard employee benefits and nine months of severance if terminated without cause. Separately, director Christopher Winkle notified the company he will resign from the Board effective May 31, 2026, and his resignation is stated not to result from any disagreement with the company.
Regional Health Properties, Inc. announced that Mark Stockslager resigned as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective April 6, 2026. The company states his resignation was not due to any disagreement regarding operations, policies or practices, and he is expected to assist in an advisory capacity during a transition period.
Effective the same date, Chairman, Chief Executive Officer and President Brent Morrison assumed the roles of Principal Financial Officer and Principal Accounting Officer on an interim basis until a successor is appointed. The company reports no current changes to either executive’s compensation arrangements related to these transitions.
Regional Health Properties, Inc. furnished an investor presentation used at the Sidoti Micro Cap Conference, outlining its vertically integrated platform spanning healthcare real estate, services, and pharmacy. The company operates 12 facilities across Ohio, Alabama, Georgia, South Carolina, and North Carolina with 1,126 licensed beds and average occupancy of 74%.
The presentation highlights an asset-backed model with 11 owned properties, clustered regional footprints, and a long-established pharmacy business serving about 1,400 beds. Total debt is $43,056 (debt amounts are presented in $000s) at a weighted average interest rate of 5.06%, with roughly 85% long term and fixed rate and about 70% non-recourse. Total capital is $92.4, including Series A, B, and D preferred equity and common equity representing 5.9% of the capital stack based on 3.9 million shares at a common stock price of $1.40. The company notes ongoing repurchases of Series B preferred at a discount to its liquidation preference and emphasizes demographic tailwinds, constrained new supply, and a strategy focused on operational improvements, pharmacy integration, and small bolt-on acquisitions.
Regional Health Properties, Inc. entered into forbearance agreements with Cadence Bank covering loan defaults tied to a $5,000,000 USDA Note and a $800,000 SBA Note, both originally due on July 27, 2036. The agreements, effective February 1, 2026, require a one-time forbearance payment of $21,047.76 and a $6,764.21 2026 USDA annual renewal fee by February 27, 2026. During the forbearance period through February 1, 2027, the company and borrower must continue monthly principal and interest payments under existing note terms. At the end of this period, remaining balances on both notes, including principal, interest, late charges and statutory attorney’s fees, become due.
Regional Health Properties, Inc. reported the results of its 2025 Annual Meeting of Shareholders held on January 5, 2026 in Atlanta. Common stockholders elected four directors to serve until the 2026 annual meeting, while holders of the Series B and Series D preferred stock each elected their designated directors.
Common stockholders approved the Amended and Restated 2023 Omnibus Incentive Compensation Plan and, by advisory vote, approved the compensation of the named executive officers. They expressed a preference to hold future Say‑on‑Pay votes every three years and ratified Cherry Bekaert, LLP as independent registered public accounting firm for the year ending December 31, 2025.
Regional Health Properties, Inc. filed an amended report to add a conformed signature that was accidentally left off an earlier filing and to describe the status of its 2025 Annual Meeting of Shareholders. The company convened the meeting on December 30, 2025, but there were not enough shares present or represented by proxy to reach a quorum, so no business was conducted and the meeting was adjourned.
The meeting is scheduled to reconvene at 1050 Crown Pointe Parkway, Suite 150, Atlanta, Georgia 30338, on January 5, 2026 at 1:00 a.m. Eastern Time to vote on the proposals already described in the proxy statement filed on December 10, 2025. The record date remains the close of business on November 14, 2025, and previously submitted proxies will be voted at the reconvened meeting unless properly revoked.
Regional Health Properties, Inc. reported that its 2025 Annual Meeting of Shareholders, convened on December 30, 2025 at 10:00 a.m. Eastern Time, was adjourned because there were not enough shares present or represented by proxy to constitute a quorum. No business was conducted at that session.
The meeting is scheduled to reconvene at 1050 Crown Pointe Parkway, Suite 150, Atlanta, Georgia 30338, on January 5, 2026 at 1:00 a.m. Eastern Time to vote on the proposals described in the proxy statement filed on December 10, 2025. The close of business on November 14, 2025 remains the record date for determining which shareholders may vote. Proxies already submitted will be voted at the reconvened meeting unless properly revoked, and the proposals and proxy materials remain unchanged.
Regional Health Properties, Inc. reported that its Board of Directors has authorized a stock repurchase plan for up to 500,000 shares of its Series B Preferred Stock. A Special Committee of the Board will oversee the timing, size, and method of these repurchases. Shares may be bought from time to time in the open market, through privately negotiated and block transactions, and under any Rule 10b5-1 trading plan, with purchases conducted in accordance with Rule 10b-18.
The company plans to fund the repurchases using cash on hand. The program does not require Regional Health Properties to buy any specific number of shares and is expected to continue indefinitely until the 500,000-share cap is reached or the Board modifies, suspends, or terminates the program.
Regional Health Properties (RHEP) completed the sale of its Coosa Valley Health and Rehab facility for $10.6 million. The buyer is an unaffiliated company. The company expects to record an approximately $3.7 million gain in the quarter ending December 31, 2025.
At closing, Regional repaid approximately $4.9 million of debt and received about $4.7 million in cash, after paying roughly $0.6 million of transaction expenses and depositing $0.4 million into escrow for unresolved tax liabilities tied to the facility. The company anticipates a portion of the escrow will be released back to it. Remaining proceeds will be used for general corporate and other purposes.
Regional Health Properties filed an 8-K/A to update its disclosure following the completion of its previously announced merger with SunLink Health Systems, effective August 14, 2025. The amendment solely supplements Item 9.01.
The company filed unaudited pro forma condensed combined financial information as Exhibit 99.1 for the six months ended June 30, 2025 and for the year ended December 31, 2024. Audited and interim SunLink financial statements were not refiled because substantially the same information was previously included in the company’s Form S-4. No shell company transactions were reported.